查看完整行情页>>

|

货币单位:美元(USD)

Acutus Medical, Inc. (afib)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Thomas Esbeck Thomas Esbeck occupies the position of Vice President-Research & Development of Acutus Medical, Inc. Mr. Esbeck received an undergraduate degree from California Polytechnic State University (San Luis Obispo).
Steven Mickelsen Founder of Field Medical, Inc. and Farapulse, Inc., Steven Mickelsen presently occupies the position of Chief Executive Officer & Director at Field Medical, Inc. He is also Chief Translational Science Officer at Acutus Medical, Inc. He previously held the position of President & Chief Executive Officer for Farapulse, Inc. and Assistant Professor at University of Iowa Hospitals & Clinics. Dr. Mickelsen received a doctorate from the University of New Mexico School of Medicine.
Gary W. Doherty Gary W. Doherty is currently the Chief Financial Officer at EBR Systems, Inc. since 2023. He is also currently the Senior Vice President-Finance at Acutus Medical, Inc. since 2015. Mr. Doherty completed his undergraduate degree at San Diego State University.
Rick Kimes Rick Kimes is currently the Senior Vice President-Operations at Acutus Medical, Inc. Prior to this, he was the Senior Vice President-Operations at Philips Image Guided Therapy Corp. He completed his undergraduate degree at the University of Utah.
Derrick Chou Derrick Chou is currently the Chief Technology Officer at Acutus Medical, Inc. He received his undergraduate, graduate, and doctorate degrees from Duke University.
Takeo Mukai Takeo Mukai is currently the Chief Executive & Financial Officer at Acutus Medical, Inc. He previously worked as the Finance Director at Medtronic, Inc. from 2007 to 2021. Mr. Mukai completed his undergraduate degree at Carnegie Mellon University in 2001 and obtained an MBA from USC Marshall School of Business in 2011.
Shaden Marzouk Shaden Marzouk is currently the Chairman at Acutus Medical, Inc., Director at Conventus Orthopaedics, Inc., and President at GenesisCare USA, Inc. They previously held positions as Chief Executive Officer-Health at Hudson's Bay Co., Chief Executive Officer & Director at Carelon Health of California, Inc., Chief Medical Officer at Cardinal Health, Inc., MD-Health & Global Health Innovation at AXA SA, President at Carelon Palliative Care, Inc., and Chief Medical Officer at Oscar Health, Inc. They also worked as an Associate at Goldman Sachs & Co. LLC. Dr. Marzouk has a background in healthcare and holds an undergraduate degree from the University of Washington, an MBA from The Fuqua School of Business, and a doctorate from Saint Louis University School of Medicine.
David P. Bonita David P. Bonita is currently an Independent Director at Acutus Medical, Inc., Prelude Therapeutics, Inc., Repare Therapeutics, Inc., Third Harmonic Bio, Inc., Treeline Biosciences, Inc., Ikena Oncology, Inc., and Secretary at Auraeda, Inc. He is also a General Partner at OrbiMed Advisors Private Equity and a Member at Orbimed Private Investments VII LP. In the past, Dr. Bonita served as Chairman at Clementia Pharmaceuticals, Inc., Independent Director at Ambit Biosciences Corp., ViewRay Technologies, Inc., and Loxo Oncology, Inc. He was also a Director at Edwards Lifesciences CardiaQ LLC, SI-BONE, Inc., ViewRay, Inc., Tricida, Inc., Enobia Pharma, Inc., Imaxio SA, Keystone Heart Ltd., Sublimity Therapeutics Ltd., Cryterion Medical, Inc., and a Finance Analyst at Morgan Stanley and UBS Securities LLC. Dr. Bonita obtained an MBA and a doctorate from The Trustees of Columbia University in The City of New York. He also holds an undergraduate degree from Harvard University.
John F. Sheridan John F. Sheridan currently works at Tandem Diabetes Care, Inc., as President, CEO & Non-Independent Director from 2019 and Acutus Medical, Inc., as Independent Director from 2021. Mr. Sheridan also formerly worked at Star Equity Holdings, Inc., as Vice President-Operations from 1998 to 2002, CardioNet LLC, as Executive Vice President-Operations from 2002 to 2004, Philips Image Guided Therapy Corp., as Executive VP-Operations, Research & Development in 2010, BioTelemetry, Inc., as Executive Vice President-Operations from 2004 to 2010, Volcano Therapeutics, Inc., as Vice President-Operations, Rapiscan Systems, Inc., as Chief Operating Officer in 2013, and hVIVO PLC, as Chief Operating Officer. Mr. Sheridan received his Masters Business Admin degree from Boston University and undergraduate degree from the University of West Florida.
Andrew ElBardissi Andrew ElBardissi is currently a Director at Endologix LLC and a Director at Conventus Orthopaedics, Inc. He is also an Independent Director at Acutus Medical, Inc. In addition, he holds director positions at Element Science, Inc., Farapulse, Inc., NeoChord, Inc., InCarda Therapeutics, Inc., Epic Sciences, Inc., V-Wave Ltd., Axon Therapies, Inc., CathWorks Ltd., MTrap, Inc., Medical Microinstruments SpA, Sema4 OpCo, Inc., Encodia, Inc., Reprieve Cardiovascular LLC, Adela, Inc., Pleno, Inc., DA32 Life Science Tech Acquisition Corp., Aurion Biotech, Inc., and Deerfield Foundation. Previously, he served as a Director at SentreHEART, Inc., Singular Genomics Systems, Inc., and GeneDx Holdings Corp. He was also an Associate at J.P. Morgan & Co., Inc. (Old) and a Vice President at Longitude Capital Management Co LLC. Dr. ElBardissi holds a graduate degree from Harvard University, an MBA from Harvard Business School, a doctorate from Mayo Clinic College of Medicine & Science, and an undergraduate degree from Schreyer Honors College.
Niamh Louise Pellegrini Niamh Louise Pellegrini is an Independent Director at Acutus Medical, Inc. She previously served as the President, Chief Executive Officer & Director at Autonomic Technologies, Inc. from 2016 to 2018. She also held positions as a Director at ViaCyte, Inc. and NeoTract, Inc., as well as a Principal at Johnson & Johnson and Lifescan, Inc. Additionally, she was the President-North American Operations at Thoratec Corp. from 2014 to 2015 and Vice President at Johnson & Johnson Innovation - JJDC, Inc. from 2009 to 2010. Ms. Pellegrini is currently the Chief Commercial Officer & Senior Vice President at Nevro Corp. until 2023. She also served as the Vice President-Global Commercial Operations at Abbott Vascular, Inc. from 2018 to 2019. Ms. Pellegrini obtained her undergraduate degree and MBA from Santa Clara University.
Jason K. Garland Jason K. Garland is an Independent Director at Acutus Medical, Inc. and the Chief Financial Officer at Repligen Corp. He previously worked as a Director at GE Industrial Solutions, CFO-Industrial Solutions Business at GE Aerospace, Divisional Vice President at Tiffany & Co., Chief Financial Officer & Executive Vice President at Integer Holdings Corp., and Chief Risk Manager at GE Aviation Systems LLC. He also served as the Chief Financial Officer at Lake Region Medical, Inc. Mr. Garland obtained his undergraduate degree from the University of New Hampshire.